Quick detection of harmful bacteria in the bloodstream to improve treatment
Rapid and automated detection of bloodborne pathogens for improved treatment and antimicrobial stewardship
This study is testing a new quick test called BactoPhore that can find harmful germs in your blood in just 2 hours, helping doctors give you the right treatment faster if you're dealing with serious infections like sepsis.
Quick facts
| Grant type | Sbir 1 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Aincobio LLC NIH-funded |
| Lab location | 1 site (Syracuse, UNITED STATES) |
| Project ID | NIH-10546973 on NIH RePORTER |
What this research studies
This research focuses on developing a rapid diagnostic test called BactoPhore that can quickly identify bloodborne pathogens, such as bacteria and fungi, directly from blood samples. Currently, detecting these pathogens takes a long time due to the need for culture growth, which can delay appropriate treatment. The BactoPhore test aims to reduce this time to just 2 hours, allowing for faster and more tailored therapies for patients suffering from conditions like sepsis. By concentrating and detecting viable pathogens quickly, this approach seeks to enhance patient outcomes and reduce the burden on healthcare systems.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients suspected of having sepsis or other serious infections caused by bloodborne pathogens.
Not a fit: Patients who do not have bloodborne infections or those who are not at risk for sepsis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce the time it takes to diagnose and treat life-threatening infections, leading to better patient outcomes.
How similar studies have performed: Other research has shown promise in rapid pathogen detection methods, indicating that this approach could be a significant advancement in clinical diagnostics.
Where this research is happening
Syracuse, UNITED STATES
- Aincobio LLC — Syracuse, United States (Active)
Researchers
- Principal investigator: Damico, Lorenzo — Aincobio LLC
- Study coordinator: Damico, Lorenzo
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.